Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 311, pseudogene (RNU6-311P) is a human pseudogene that shares sequence similarity with the U6 small nuclear RNA (snRNA), an essential RNA of the spliceosome complex required for pre-mRNA splicing. Unlike the functional U6 snRNA, RNU6-311P is classified as a pseudogene, meaning it is generally not transcribed or functional as a mature RNA molecule, nor is it involved in canonical splicing activity[4][5]. Pseudogenes like RNU6-311P do not encode proteins or functional RNAs and are not considered therapeutic targets. They are typically the result of gene duplication or retrotransposition events and may be used as genomic markers or in evolutionary studies, but they are not known to play a direct role in disease mechanisms or as drug targets[2][4][5]. Key notes: - RNU6-311P is catalogued in human gene databases and identified as a pseudogene without known functional RNA expression or direct biological activity[4][5]. - Functional U6 snRNA genes are highly conserved and essential for spliceosome assembly and RNA splicing, but pseudogenes like RNU6-311P represent inactive genomic copies without such roles[3][5]. - No evidence exists for direct disease association, biomarker use, or drug targeting for this specific pseudogene[4][5]. - Many U6-derived pseudogenes exist in the vertebrate genome, reflecting the evolutionary importance of the original U6 gene, but these pseudogenes generally lack functional significance[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 311, pseudogene (RNU6-311P).